Armistice Capital »

Vsee Health shares owned by Armistice Capital

Quarter-by-quarter ownership of Vsee Health (VSEE) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Vsee Health

Tip: Access up to 7 years of quarterly data

All positions including Vsee Health held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vsee Health by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $875k 3.5M 0.25

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Vsee Health

Armistice Capital
Geode Capital Management
Vanguard Capital Management
Cygnus Capital Advisors
Advisor Group Holdings
Virtu Financial
UBS Group
State Street Corporation
Wealthcare Advisory Partners
Vanguard Group
Susquehanna International
CWM
Tower Research Capital
Vanguard Fiduciary Trust
SBI Securities

View all funds holding Vsee Health